Skip to main content
Premium Trial:

Request an Annual Quote

Biocius Life Sciences Forms after Life Tech's Biotrove Acquisition

NEW YORK (GenomeWeb News) – Biocius Life Sciences said today that it is now an independent operating company after completing its spin out from parent company Biotrove, which was recently acquired by Life Technologies.

Biocius said that it now holds all of the intellectual property related to the RapidFire mass spectrometry platform formerly owned by Biotrove; and that it will employ all former employees of Biotrove's RapidFire business unit.

In November, Life Technologies announced that it would acquire BioTrove for an undisclosed sum to incorporate Biotrove's OpenArray high-throughput gene expression and genotyping system.

At the time, Biotrove said that it would form the Biocius subsidiary to retain the RapidFire business. Life Tech's acquisition of Biotrove was completed yesterday.

Biocius' investors include Catalyst Health Ventures, Excel Venture Management, Fletcher-Spaght, CB Health Ventures, Vox Equity Partners, Echelon Ventures, and BioFrontier Partners.

Biocius, based in Woburn, Mass., said that it will focus its resources on further developing and marketing the RapidFire platform, as well as new research and development projects to facilitate drug discovery for clients and collaborators.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.